PRESS RELEASE published on 03/31/2025 at 09:04, 11 months 26 days ago EQS-Adhoc: elumeo SE decides on restructuring program of EUR 5.9 million for 2025 and lowers forecast for 2024 elumeo SE announces a EUR 5.9 million restructuring program for 2025 and revises down 2024 forecast, focusing on higher-priced jewelry and cost-cutting measures Elumeo SE Cost-cutting Measures Restructuring Program Jewelry Market 2025 Forecast
PRESS RELEASE published on 11/18/2024 at 16:22, 1 year 4 months ago Original-Research: Elumeo SE (von Montega AG): Halten Montega AG stuft Elumeo SE mit Halten und Kursziel von 2,15 EUR, trotz schwierigem Marktumfeld und Kostensenkungsprogramm, ein. Details zum Unternehmen und zur aktuellen Entwicklung Montega AG Elumeo SE Kostensenkungsprogramm Jahresprognose Haltungsempfehlung
BRIEF published on 11/14/2024 at 08:05, 1 year 4 months ago Elumeo SE maintient sa stabilité sur un marché difficile au troisième trimestre 2024 Elumeo SE Gestion Des Coûts Bijoux En Pierres Précieuses Confiance Des Consommateurs 3e Trimestre 2024
BRIEF published on 11/14/2024 at 08:05, 1 year 4 months ago Elumeo SE Maintains Stability in Challenging Q3/2024 Market Elumeo SE Q3 2024 Cost Management Gemstone Jewelry Consumer Confidence
PRESS RELEASE published on 11/14/2024 at 08:00, 1 year 4 months ago elumeo SE continues to hold its own in Q3/2024 in a persistently difficult market en-vironment elumeo SE maintains stability in Q3/2024 despite challenging market conditions with sales almost steady at EUR 33.0 million and positive adjusted EBITDA of EUR 0.44 million Adjusted EBITDA Market Conditions Elumeo SE Sales Stability Q3/2024
BRIEF published on 10/25/2024 at 07:46, 1 year 5 months ago Elumeo SE Announces Capital Increase with 250,000 New Shares European Market Capital Increase Elumeo SE Equity Ratio Gemstone Jewelry
BRIEF published on 10/25/2024 at 07:46, 1 year 5 months ago Elumeo SE annonce une augmentation de capital avec 250 000 nouvelles actions Augmentation De Capital Marché Européen Elumeo SE Bijoux En Pierres Précieuses Ratio De Fonds Propres
PRESS RELEASE published on 10/25/2024 at 07:41, 1 year 5 months ago EQS-Adhoc: elumeo SE: Capital increase of 250,000 shares at EUR 2 per share Berlin, 25 October 2024 elumeo SE resolves capital increase of 250,000 shares at EUR 2 per share to improve equity ratio. New shares issued to strategic investor. Dividend rights from 1 Jan 2024 Shares Capital Increase Elumeo SE Equity Ratio Dividend Rights
PRESS RELEASE published on 10/14/2024 at 11:46, 1 year 5 months ago Original-Research: elumeo SE (von Montega AG): Halten elumeo SE von Montega AG eingestuft: Initiation of Coverage mit Halten-Empfehlung und 2,15 EUR Kursziel. Echtzeit-Übersetzungen für TV-Shopping-Sender Juwelo-TV eröffnen Wachstumschancen und Auslandsexpansion geplant Montega AG Aktienanalyse Elumeo SE Direktvertrieb Edelsteinschmuck
BRIEF published on 10/04/2024 at 09:44, 1 year 5 months ago Elumeo SE révise ses prévisions pour 2024 en raison des défis économiques Elumeo SE Réduction Des Coûts Confiance Des Consommateurs Prévisions Pour 2024 Internationalisation 2.0
Published on 03/26/2026 at 21:00, 24 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 21:00, 24 minutes ago Rocky Shore Closes Acquisition of Additional Mining Claims
Published on 03/26/2026 at 16:20, 5 hours 4 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 8 hours 24 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 20:48, 35 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 2 hours 3 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 2 hours 14 minutes ago 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 2 hours 14 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 3 hours 7 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 3 hours 7 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 3 hours 24 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 3 hours 24 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
